ArticleNeuro-oncology2024

Corrigendum to: LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.